• |
  • |
  • |
  • |
Donate

Project

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279

Center:
Fiscal Year:
2017
Contact Information:
Project Description:
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Male Subjects with Autism Spectrum Disorder.
Keyword(s):
Core Function(s):
Area of Emphasis
Health-Related Activities
Target Audience:
Adults with Disabilities, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
National
Funding Source:
COVID-19 Related Data:
N/A